A multi-center, double-blind, randomized, placebo-active-controlled, dose-ranging study to evaluate the efficacy and safety of Actelion-1 in subjects with mild-to-moderate essential hypertension.
Latest Information Update: 14 Aug 2014
At a glance
- Drugs Macitentan (Primary) ; Enalapril
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 14 Aug 2014 New trial record